Blistering conditions manifest with fluid-filled skin lesions, vesicles, and bullae, often leading to erosions covered by crusts. These conditions encompass both inherited and acquired disorders, some frequent and other rare, some mild and other severe, possibly life endangering. Autoimmune blistering diseases can be caused by immune system dysfunction. Management aims to alleviate pain, prevent infections, and promote epithelialization, often involving immunosuppressive medications. Wound care presents challenges due to skin fragility and immunosuppressive effects of the medication, necessitating gentle cleaning, appropriate drainage techniques, and protective dressings. Topical treatments and oral care are integral, alongside pain management and infection monitoring. Stevens-Johnson syndrome and toxic epidermal necrolysis, drug-related mucocutaneous diseases, demand meticulous care to prevent epidermal detachment and infection. Inherited epidermolysis bullosa poses challenges in wound healing due to skin fragility, requiring specialized wound care approaches. Research into novel therapies, such as gene therapy, offers hope for improved management. Multidisciplinary care, nutritional support, and preventive strategies, particularly in neonates, are crucial for optimizing outcomes. Understanding the complexities of blistering conditions and tailoring management strategies are paramount in enhancing patient care and quality of life.